A detailed history of Rothschild Investment Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Rothschild Investment Corp holds 34,178 shares of ABT stock, worth $4.02 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
34,178
Previous 33,373 2.41%
Holding current value
$4.02 Million
Previous $3.64 Million 9.02%
% of portfolio
0.28%
Previous 0.3%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023

BUY
$95.53 - $114.62 $76,901 - $92,269
805 Added 2.41%
34,178 $3.31 Million
Q2 2023

Jul 18, 2023

SELL
$100.78 - $112.29 $33,358 - $37,167
-331 Reduced 0.98%
33,373 $3.64 Million
Q1 2023

Apr 24, 2023

BUY
$96.86 - $114.01 $69,836 - $82,201
721 Added 2.19%
33,704 $3.41 Million
Q4 2022

Jan 19, 2023

BUY
$95.06 - $111.52 $45,818 - $53,752
482 Added 1.48%
32,983 $3.62 Million
Q3 2022

Oct 21, 2022

BUY
$96.76 - $112.03 $6,482 - $7,506
67 Added 0.21%
32,501 $3.15 Million
Q2 2022

Jul 12, 2022

BUY
$102.07 - $123.37 $24,700 - $29,855
242 Added 0.75%
32,434 $3.52 Million
Q1 2022

Apr 18, 2022

BUY
$114.02 - $139.04 $106,608 - $130,002
935 Added 2.99%
32,192 $3.81 Million
Q4 2021

Jan 24, 2022

BUY
$115.53 - $141.46 $16,751 - $20,511
145 Added 0.47%
31,257 $4.4 Million
Q3 2021

Oct 12, 2021

SELL
$116.66 - $129.06 $1.31 Million - $1.45 Million
-11,206 Reduced 26.48%
31,112 $3.68 Million
Q2 2021

Jul 19, 2021

SELL
$105.79 - $124.53 $213,378 - $251,177
-2,017 Reduced 4.55%
42,318 $4.91 Million
Q1 2021

Apr 15, 2021

SELL
$108.84 - $128.23 $10,557 - $12,438
-97 Reduced 0.22%
44,335 $5.31 Million
Q4 2020

Jan 25, 2021

BUY
$105.0 - $114.42 $15,750 - $17,163
150 Added 0.34%
44,432 $4.87 Million
Q3 2020

Oct 22, 2020

BUY
$91.64 - $111.29 $69,921 - $84,914
763 Added 1.75%
44,282 $4.82 Million
Q2 2020

Jul 24, 2020

SELL
$76.57 - $98.0 $3.28 Million - $4.2 Million
-42,866 Reduced 49.62%
43,519 $3.98 Million
Q1 2020

Apr 16, 2020

BUY
$62.82 - $91.86 $31,724 - $46,389
505 Added 0.59%
86,385 $6.82 Million
Q4 2019

Jan 22, 2020

BUY
$78.51 - $87.4 $266,934 - $297,160
3,400 Added 4.12%
85,880 $7.46 Million
Q3 2019

Oct 11, 2019

SELL
$81.84 - $88.74 $56,060 - $60,786
-685 Reduced 0.82%
82,480 $6.9 Million
Q2 2019

Jul 11, 2019

BUY
$72.88 - $85.0 $561,176 - $654,500
7,700 Added 10.2%
83,165 $6.99 Million
Q1 2019

Apr 18, 2019

SELL
$66.22 - $80.06 $749,610 - $906,279
-11,320 Reduced 13.04%
75,465 $6.03 Million
Q4 2018

Jan 28, 2019

BUY
$65.56 - $74.27 $541,722 - $613,693
8,263 Added 10.52%
86,785 $6.28 Million
Q3 2018

Oct 17, 2018

BUY
$60.81 - $73.36 $1.2 Million - $1.45 Million
19,742 Added 33.59%
78,522 $5.76 Million
Q2 2018

Jul 24, 2018

BUY
$57.57 - $63.54 $460 - $508
8 Added 0.01%
58,780 $3.59 Million
Q1 2018

Apr 27, 2018

SELL
$56.27 - $63.62 $144,895 - $163,821
-2,575 Reduced 4.2%
58,772 $3.52 Million
Q4 2017

Jan 23, 2018

BUY
$53.68 - $57.47 $29,953 - $32,068
558 Added 0.92%
61,347 $3.5 Million
Q3 2017

Oct 25, 2017

BUY
$48.06 - $53.64 $2.92 Million - $3.26 Million
60,789
60,789 $3.24 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Rothschild Investment Corp Portfolio

Follow Rothschild Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment Corp with notifications on news.